Director/PDMR Shareholding

RNS Number : 0523S

GlaxoSmithKline PLC

01 November 2019

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms E Walmsley
b)	Position/status	Chief Executive Officer
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The exercise of options over 137,040 Ordinary Shares, granted on 22 July 2010 under the GlaxoSmithKline 2009 Share Option Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) £12.035 137,040
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date of the transaction	2019-10-31
f)	Place of the transaction	N/A

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms E Walmsley
b)	Position/status	Chief Executive Officer
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The sale of 112,945 Ordinary Shares to cover the tax and cost of exercise of the options granted on 22 July 2010 under the GlaxoSmithKline 2009 Share Option Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) £17.7588 112,945
d)	Aggregated information Aggregated volume Price	N/A (single transaction)
e)	Date of the transaction	2019-10-31
f)	Place of the transaction	London Stock Exchange (XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms E Walmsley
b)	Position/status	Chief Executive Officer
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Transfer of 24,095 Ordinary Shares to spouse for nil consideration.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£0.00	24,095
d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2019-10-31
f)	Place of the transaction	N/A

	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr David Owen
b)	Position/status	PCA of Ms E Walmsley (Chief Executive Officer)
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Receipt of 24,095 Ordinary Shares from spouse for nil consideration.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£0.00	24,095
d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2019-10-31
f)	Place of the transaction	N/A

 

END

 

 

DSHDFLFBKFFFFBE